Ptc Therapeutics, Inc. · NASDAQ:PTCT

Schmertzler Michael sold 2,500 Ptc Therapeutics, Inc. shares (Form 4)

Traded Oct 14, 2026 · Filed Oct 16, 2026

On Oct 14, 2026, Schmertzler Michael (Director) sold 2,500 Ptc Therapeutics, Inc. shares at an average US$59.61 for US$149K under a trading plan, leaving 1,291,594 shares. Filed Oct 16, 2026 (Form 4).

Sold
2,500 shares
Price
US$59.61 average (US$59.52 to US$60.14)
Value
US$149K
Holding after
1,291,594 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 14, 2026Common StockSale2,118US$59.521,291,976Indirect
Oct 14, 2026Common StockSale382US$60.141,291,594Indirect

Source

Download original · View original at SEC

Related